Clinical trial NCT00597168: Quality of Life in Schizophrenic Patients
Official title: QUALITY: A Non-interventional Study Evaluating Quality Of Life in Schizophrenic Patients Treated With Atypical Antipsychotics, in the Ambulatory Setting. A 9-month, Observational, Multicentric Prospective Study.
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Schizophrenia
Keywords: Schizophrenia
atypical antipsychotic
quality of life
ambulatory setting
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2008-01-17
Enrollment: 124
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Ambulatory patients

Brief summary: This is a non-interventional study evaluating quality of life in schizophrenic patients treated with atypical antipsychotics, in the ambulatory setting. This is a 9-month, observational, multicentric prospective study.


Eligibility criteria: Inclusion Criteria:

* Patients diagnosed with Schizophrenia treated with atypical antipsychotics (ambulatory patients).

Primary outcomes:
measure: Change from baseline of QOL assessed by the SWN-K after 9 months of treatment with AAPs.
timeFrame: 9 months
Secondary outcomes:
Other outcomes:
Locations:
city: Aalst
country: Belgium
facility: Research Site
city: Asse
country: Belgium
facility: Research Site
city: Bertrix
country: Belgium
facility: Research Site
city: Bierbeek
country: Belgium
facility: Research Site
city: Boechout
country: Belgium
facility: Research Site
city: Bon-secours
country: Belgium
facility: Research Site
city: Bruxelles
country: Belgium
facility: Research Site
city: Dendermonde
country: Belgium
facility: Research Site
city: Diest
country: Belgium
facility: Research Site
city: Duffel
country: Belgium
facility: Research Site
city: Eeklo
country: Belgium
facility: Research Site
city: Elsene
country: Belgium
facility: Research Site
city: Embourg
country: Belgium
facility: Research Site
city: Floreffe
country: Belgium
facility: Research Site
city: Gent
country: Belgium
facility: Research Site
city: Halle
country: Belgium
facility: Research Site
city: Henri-Chapelle
country: Belgium
facility: Research Site
city: Herstal
country: Belgium
facility: Research Site
city: Jambes
country: Belgium
facility: Research Site
city: Kortenberg
country: Belgium
facility: Research Site
city: Kortrijk
country: Belgium
facility: Research Site
city: La Louviere
country: Belgium
facility: Research Site
city: Leut
country: Belgium
facility: Research Site
city: Leuven
country: Belgium
facility: Research Site
city: Libramont
country: Belgium
facility: Research Site
city: Liege
country: Belgium
facility: Research Site
city: Lierneux
country: Belgium
facility: Research Site
city: Melle
country: Belgium
facility: Research Site
city: Menen
country: Belgium
facility: Research Site
city: Mol
country: Belgium
facility: Research Site
city: Mons
country: Belgium
facility: Research Site
city: Oostende
country: Belgium
facility: Research Site
city: Ottignies
country: Belgium
facility: Research Site
city: Roeselare
country: Belgium
facility: Research Site
city: Schaerbeek
country: Belgium
facility: Research Site
city: Sint-Kruis (Brugge)
country: Belgium
facility: Research Site
city: Sint-Lambrechts-Woluwe
country: Belgium
facility: Research Site
city: Sint-Michiels
country: Belgium
facility: Research Site
city: Sint-Niklaas
country: Belgium
facility: Research Site
city: Sint-Truiden
country: Belgium
facility: Research Site
city: Sleidinge
country: Belgium
facility: Research Site
city: Tielt
country: Belgium
facility: Research Site
city: Tienen
country: Belgium
facility: Research Site
city: Veurne
country: Belgium
facility: Research Site
city: Waregem
country: Belgium
facility: Research Site
city: Woluwe-Saint-Lambert
country: Belgium
facility: Research Site
Study officials:
affiliation: UZ Leuven
name: Prof Vermylen
role: PRINCIPAL_INVESTIGATOR
References: